Globus Medical price target raised to $88 from $78 at Wells Fargo

Wells Fargo analyst Vik Chopra raised the firm’s price target on Globus Medical (GMED) to $88 from $78 and keeps an Overweight rating on the shares. The firm believes a solid Q3 print, another guidance raise and upward consensus revisions should drive the stock higher from here and raise investor confidence.